Stanford University: Centers for Cancer Nanotechnology Excellence

Company Information

Alternative Name(s): 
Molecular Imaging Program (MIP)
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR)
Street 1: 
The James H Clark Center
Street 2: 
318 Campus Drive
City: 
Stanford
State: 
CA
Postal Code: 
94305-5427
Country: 
United States
Phone Number: 
650-725-6175
Year Established: 
2003
Employment: 
21
Employment Year: 
2013
References in Nano Datasets: 
1

Description: 

The Molecular Imaging Program at Stanford (MIPS) was established as an inter-disciplinary program to bring together scientists and physicians who share a common interest in developing and using state-of-the-art imaging technology and developing molecular imaging assays for studying intact biological systems.

Within the MIP is the Center for Cancer Nanotechnology Excellence and Translation (CCNE-T), one of nine National Cancer Institute funded centers (2010-2015). The primary focus of the CCNE-T is to develop and use nanotechnology for monitoring response to anti-cancer therapy and for earlier cancer detection. The cancer focus in the CCNE is on both lung and ovarian cancers; however developed strategies may eventually be applied to many cancers. In 2005-2010, the first NCI award for a CCNE to Stanford created the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR). This was one of eight centers in established in the first funding cycle in 2005.

Value Chain Mapping

Firm or Supporting Organization: 
Supporting Organization
Support Stakeholder Group(s): 
Industry Sector(s): 
Value-Adding Activities: